Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 546244Generated: November 1, 2026

Toluene → HCID 67189504, compound

https://huagongshe.com/reaction/546244

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTolueneHCID 1140—
ReactantPotassium CarbonateHCID 11430—
ReactantSodium SulfiteHCID 24437—
ReactantMethanesulfonamideHCID 72879—
ReactantHCID 67188926HCID 67188926—
CatalystOsmium TetroxideHCID 30318—
Catalyst1-((1R)-((2R,4R,5S)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)-4-((1R)-((2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methoxy)phthalazineHCID 51003674—
CatalystHCID 178511488HCID 178511488—
SolventWaterHCID 962—
SolventEthyl AcetateHCID 8857—
Solvent2-Methylpropan-2-ol--water (1/1)HCID 71401949—
ProductHCID 67189504HCID 6718950463%

Reaction Conditions

Temperature25 °C

Reaction Steps

A mixture of potassium ferricyanide (21 mg, 0.06 mmol), potassium carbonate (8.9 mg, 0.06 mmol), and (DHQ)2PHAL (0.3 mg, 3%) was treated with a solution of water/tert-butyl alcohol (5 mL, 1:1) and stirred at 25° C. for 5 min (until clear solution obtained). The reaction mixture was treated with a 0.2 M solution of osmium tetroxide in toluene (1μ, 1%) and cooled to 0° C. To this was added 2-(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[1-(3-methyl-but-2-enyl)-1H-pyrazol-3-yl]-propionamide (prepared as in Example 51, 10 mg, 0.022 mmol) and methane sulfonamide (2 mg, 0.02 mmol). The heterogeneous mixture was stirred at 0° C. for 20 h. After such time the cooling bath was removed and the mixture was treated while stirring with ethyl acetate (15 mL) and sodium sulfite (50 mg, 0.39 mmol). To this solution was added water (20 mL) and the phases were separated. The aqueous phase was backextracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. Purification an AnaLogix Intelliflash system (4 g column, 70% ethyl acetate/hexanes to 100% ethyl acetate) afforded (R)-2-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[1-(2,3-dihydroxy-3-methyl-butyl)-1H-pyrazol-3yl]propionamide (6.7 mg, 63%) as a single diastereomer of unknown stereochemistry at the hydroxyl carbon center: [α]29589=−10.2° (c=0.48, methanol); ES-HRMS m/e calcd for C23H32ClN3O5S (M+H)+ 498.1824, observed 498.1824; 1H NMR (400 MHz, DMSO-d6) δ ppm 1.05 (s, 3H, CH3), 1.09 (s, 3H, CH3), 1.11 (m, 2H, CH2) 1.39-1.79 (m, 8H, 4×CH2), 2.10 (m, 1H, CH), 3.34 (s, 3H, SO2CH3), 3.46 (m, 1H, OCH), 3.75 (dd, J=9.6 Hz, 13.5 Hz, 1H, NCH of NCH2), 3.90 (m, 1H, ArCHCO), 4.21 (d, J=13.5 Hz, 1H, NCH of NCH2), 4.42 (s, 1H, OH), 4.82 (d, J=6.3 Hz, 1H, OH), 6.39 (d, J=2.3 Hz, 1H, Ar), 7.51 (d, J=2.3 Hz, 1H, Ar), 7.59 (dd, Jo=8.3, Jm=1.6 Hz, 1H, Ar), 7.70 (d, Jm=1.6 Hz, 1H, Ar), 8.01 (d, Jo=8.3 Hz, 1H, Ar), 10.78 (s, 1H, NH).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07935699B2
Source datasetuspto-grants-2011_05
ORD IDord-95a3eea5cc7a410e90f4807db6009252
Source noteuspto-grants-2011_05